U.S. court bars Martin Shkreli from pharma industry, orders $64.6 million payment

By:  Reuters
02:14 01/14/2022

WASHINGTON (Reuters) - A U.S. court said on Friday that Martin Shkreli, who famously raised the price of Daraprim, would be ordered to pay $64.6 million and would be barred for life from the pharmaceutical industry.

The drug is used to treat toxoplasmosis, a parasitic infection that threatens people with weakened immune systems.

(Reporting by Diane Bartz)

This article has been provided by a DearWallstreet contributor. All content submitted by this author represent their personal opinions, and should be considered as such for entertainment purpose only. All opinions expressed are those of the writer, and may not necessarily represent fact, opinions, or bias of DearWallstreet.